250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotech Startup Investors in Australia

A list of 50 angel investors and VC funds that invest in Biotech startups based in Australia. We rank investors based on the number of investments they made in Biotech companies from Australia. We update this investor list every month.

Top 50 Biotech Startup Investors in Australia

Investor Biotech Australia investments
Uniseed Ventures 21
Brandon Capital Partners 15
Medical Research Commercialisation Fund (MRCF) 11
Stoic VC 7
OneVentures 6
Artesian VC 5
Melbourne Angels 5
Main Sequence Ventures 4
Clean Energy Finance Corporation 3
Horizons Ventures 3
Yuuwa Capital 3
Starfish Ventures 3
Lowercarbon Capital 2
Folklore Ventures 2
Grok Ventures 2
South Australian Venture Capital Fund 2
Sydney Angels 2
Possible Ventures 2
BridgeLane Capital 2
Global Health Investment Fund (GHIF) 2
Allan Moss 2
Brisbane Angels 2
Vectr 2
Square Peg Capital 1
Regal Funds Management 1
Innovation Capital 1
Hitachi Ventures 1
QIC BioVentures 1
Twynam Agricultural Group 1
AustralianSuper 1
BioScience Managers Limited 1
Lilly Ventures 1
Negev Capital 1
Hostplus 1
Lionheart Ventures 1
Catherine Lacavera 1
Daniel Petre 1
Investible 1
Tenacious Ventures 1
NOAB Ventures 1
Plymouth Growth 1
Bioplatforms Australia 1
Australian Nuclear Science and Technology Organization 1
Time Ventures 1
Alium Capital 1
HealthCare Ventures 1
Mercia Fund Managers 1
Southern Cross Venture Partners 1
Giant Leap Fund 1
CP Ventures 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Uniseed Ventures VC Fund · Brisbane, Queensland, Australia · 2 investments in the past 12 months
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Funding Round
  • Australia, United States, United Kingdom
Portfolio highlights
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
  • Morse Micro — Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah. 10X FARTHER>1Km range, 100x area, 1000x volume 10X EFFICIENCYMulti-year on a single
Brandon Capital Partners VC Fund · Melbourne, Victoria, Australia · 4 investments in the past 12 months
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Entact Bio — Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Medical Research Commercialisation Fund (MRCF) VC Fund · Melbourne, Victoria, Australia
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
  • Glyscend — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
Stoic VC VC Fund · Sydney, New South Wales, Australia
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Seed, Funding Round, Series A
  • Australia, United States, United Kingdom
Portfolio highlights
  • Lenexa Medical — Lenexa Medical is driving towards better healthcare solutions for patients in hospital and aged-care by preventing pressure injuries and empowering clinicans.
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
OneVentures VC Fund · Sydney, New South Wales, Australia · 4 investments in the past 12 months
OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Series A, Debt Financing, Funding Round
  • Australia, United States, Israel
Portfolio highlights
  • ImmVirX — ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect.
  • BiVACOR — BiVACOR is a privately held company founded in 2008. Their staff includes world-class engineers, medical specialists, and business executives, who are diligently working to advance this ground-breaking technology. Together, they have established a strong collaborative network that extends both nationally and internationally. Their worldheadquarters is located in Houston, Texas, USA, and their international office is in Brisbane, Australia.
  • Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
Artesian VC VC Fund · Melbourne, Victoria, Australia · 16 investments in the past 12 months
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Pre-Seed
  • Australia, United States, Hong Kong
Portfolio highlights
  • Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
  • ZoomAgri — ZOOMAGRI provides an assessment of agricultural commodities to all participants of Agri supply chain via AI, computer vision and IoT.
  • Supplynote — End-to-end supply chain management tool to track inventory, orders, payments and suppliers online
Melbourne Angels VC Fund · Melbourne, Victoria, Australia
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more
Investment focus
  • Biotechnology, Information Technology, Manufacturing
  • Angel, Seed, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Apop Imaging — Apop Imaging develops and commercialises novel imaging, diagnostic and therapeutic tools to improve patient outcomes based on our proprietary calcitonin receptor antibody technology.
  • Tayble — Spend more time enjoying your food and less time waiting.We hate waiting...For anything...And food and drinks are no exception!If your hobbies include:- Waiting in line - Calling out to a waiter - Watching the kettle boil - Calculating your split of the billPLEASE DO NOT DOWNLOAD THIS APP... YOU'LL HATE IT!But if you're likeus...And want your food and drinks ready exactly when you are...Or to leave a restaurant without worrying about your bill...Then step right up, this bad boy's for you!With Tayble, you’ll never have to flag down a waiter... EVER!Simply order from your "Tayble"Or before you even arrive...Leave the rest to us and the 1,000's of minions in the cloud that keep this all running!You’ll be left asking where has this been all my life, guaranteed!*(Definitely not a real guarantee)
Main Sequence Ventures VC Fund · Sydney, New South Wales, Australia · 15 investments in the past 12 months
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Series A, Seed, Series B
  • Australia, United States, Philippines
Portfolio highlights
  • Number 8 bio — Number 8 bio objective is to decarbonize agriculture while feeding the world's rising population. This can be accomplished by harnessing the power of trillions of carbon-hungry bacteria that feed on harmful greenhouse gases and turn them into profitable animal feeds.
  • Jdoodle — JDoodle is an Online Compiler, Editor, IDE for Java, C, C++, PHP, Perl, Python, Ruby and many more. You can run your programs on the fly online, and you can save and share them with others. Quick and Easy way to compile and run programs online.
  • Endua — Endua is building the next generation of clean energy deep storage to power communities, remote industries and off-grid infrastructure at the flick of a switch - all day and night
Clean Energy Finance Corporation VC Fund · Sydney, New South Wales, Australia · 9 investments in the past 12 months
The Clean Energy Finance Corporation invests, applying commercial rigour, to increase the flow of finance into the clean energy sector. Their mission is to accelerate Australia's transformation towards a more competitive economy in a carbon constrained world, by acting as a catalyst to increase investment in emissions reduction. They do thisthrough an investment strategy focused on cleaner power solutions, including large and small-scale solar, wind and bioenergy; and a better built environment, with investments to drive more energy efficient property, vehicles, infrastructure and industry. The CEFC also invests with co-financiers to develop new sources of capital for the clean energy sector, including climate bonds, equity funds, aggregation facilities and other financial solutions. The CEFC operates under the Clean Energy Finance Corporation Act 2012.
Show more
Investment focus
  • Energy, Solar, Renewable Energy
  • Series B, Series A, Seed
  • Australia, United States
Portfolio highlights
  • Gunn Agri Partners — Gunn Agri Partners is an agricultural investment company that offers advice and services for acquisitions, asset, farm, and fund management.
  • HydGene Renewables — Our mission is to accelerate adoption of low carbon technology by providing an alternative green hydrogen solution.
  • Infradebt — Infradebt t is a specialist fund manager providing clients with direct access to infrastructure private debt markets.
Horizons Ventures VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 12 investments in the past 12 months
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more
Investment focus
  • Biotechnology, Artificial Intelligence, Software
  • Series A, Series B, Seed
  • United States, United Kingdom, Israel
Portfolio highlights
  • Cortical Labs — Cortical Labs are creators of the dishbrain that fuses living brain cells onto computing devices to create machines with biological intelligence
  • Cauldron Ferm — Cauldron is sustainably delivering the precision fermented prototypes of today to the supermarket shelves of tomorrow.
  • Matchday — We build games for 5B football fans, featuring your favorite players. Official partner of FIFA and FIFPRO.
Yuuwa Capital VC Fund · Perth, Western Australia, Australia
Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.
Show more
Investment focus
  • Biotechnology, Analytics, Health Care
  • Series A, Seed, Series B
  • Australia
Portfolio highlights
  • Nexgen Plants Pty Limited — Healthy plants, healthy people, living planet. Nexgen develop's plants for future generations that will improve the environment and health of future generations.
  • icetana — icetana Motion Intelligence dramatically improves the active monitoring of security surveillance networks, with AI video anomaly detection and video analytics.
  • Agworld Pty Ltd — Agworld Farm Management software allows you to collect data at all levels and enables you to extract maximum value from this data; optimising profitability. The Agworld ecosystem is utilised by growers, agronomists and service providers on farms across the world.
Starfish Ventures VC Fund · Melbourne, Victoria, Australia
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more
Investment focus
  • Software, Enterprise Software, Information Technology
  • Series A, Series B, Funding Round
  • United States, Australia, Philippines
Portfolio highlights
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,133,013 freelance designers compete to create amazing designs for your business. Start Today!
  • Marani — Marani Health is developing a prenatal care platform which includes a wearable, textile-based product to measure key vital statistics of women and their developing fetus, for use during pregnancy, labor & delivery. The products utilize Artificial Intelligence to better assess health & wellness during pregnancy, labor & delivery. Maraniis collaborating with key partners including The Mayo Clinic.
  • Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
Lowercarbon Capital VC Fund · New York, New York, United States · 32 investments in the past 12 months
Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.
Show more
Investment focus
  • Biotechnology, Renewable Energy, Energy
  • Seed, Series A, Funding Round
  • United States, United Kingdom, France
Portfolio highlights
  • Dioxycle — Dioxycle is develop electrolyser solutions for carbon dioxide emissions.
  • Isometric — Isometric is a carbon removal registry and science platform
  • Crux — The ecosystem for developers, tax credit buyers, and financial institutions to transact & manage transferable tax credits.
Folklore Ventures VC Fund · Sydney, New South Wales, Australia
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Show more
Investment focus
  • Software, Apps, Information Technology
  • Seed, Series A, Funding Round
  • Australia, New Zealand, United States
Portfolio highlights
  • SimConverse — SimConverse is a simulation platform that uses generative AI to play the role of any patient, colleague or casualty.
  • HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
  • Swoop Aero — Transforming how the world moves by making access to the skies seamless.
Grok Ventures VC Fund · Surry Hills, New South Wales, Australia · 5 investments in the past 12 months
Grok Ventures is a private investment company. They back world-class teams solving big problems to shape a better future. They invest in fast growing technology-enabled businesses.
Show more
Investment focus
  • Renewable Energy, Software, Internet of Things
  • Series A, Series B, Seed
  • Australia, United States, Hong Kong
Portfolio highlights
  • Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
  • Loam Bio — Loam Bio is developing tech that allows for crops to be inoculated with symbiotic micro-organisms.
  • WeaveGrid — WeaveGrid operates with utilities and owners of electric vehicles (EV) to allow and speed up transportation electrification. Using machine learning, optimization, and predictive analytics, the company's software solution solves several EV-grid integration challenges for utilities in a systems-oriented manner; helps integrate renewable energyresources on the grid; and saves utility customers' money on their bills.
South Australian Venture Capital Fund VC Fund · Adelaide, South Australia, Australia
South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.
Show more
Investment focus
  • Health Care, Biotechnology, SaaS
  • Funding Round, Series A, Series B
  • Australia
Portfolio highlights
  • BiomeBank — BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.
  • Lumary — Simplify Your Care Management Optimise Your Organisation Create Better Wellbeing
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Sydney Angels VC Fund · Sydney, New South Wales, Australia
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more
Investment focus
  • Software, SaaS, Apps
  • Seed, Funding Round, Angel
  • Australia, United States
Portfolio highlights
  • Trendspek — Trendspek is the drone data solution asset managers use to make empowered decisions and ensure absolute asset knowledge. Conduct complete visual inspections from any web browser. Extract detailed insights without a site visit. Use powerful tools to analyse the structure and build a complete picture of asset condition. Enhance predictive maintenanceby closely monitoring trends. View different models side by side to observe important differences. Refine your understanding of an ever-changing asset.
  • Remi AI — A.I-Powered Demand Forecasting, Supply Chain AI, & Price Optimisation | Remi AI
  • Kapiche — Instant insights. No set up or coding. The Kapiche feedback analytics platform helps you ingest and analyze mountains of customer feedback in minutes.
Possible Ventures VC Fund · Munich, Bayern, Germany · 24 investments in the past 12 months
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more
Investment focus
  • Software, Information Technology, Biotechnology
  • Seed, Pre-Seed, Series A
  • Germany, Australia, United States
Portfolio highlights
  • Auriga Space — Next-generation space launch company providing frequent, sustainable and affordable transport to low Earth orbit
  • Chemify — The aim of Chemify is to digitize chemistry and produce solutions to run chemical code for drug discovery, chemical synthesis, and materials discovery.
  • Tilebox Inc. — Tilebox is a fully integrated midstream cloud platform designed for space companies to simplify their midstream operations. Its secure, high-performance, and scalable solution accelerates time-to-market and optimizes costs, empowering space companies to unlock the full potential of their assets.By leveraging Tilebox, space companies can deriskand ensure maximum satellite lifetime utilization, optimize cloud processing and accelerate revenue generation. Tilebox serves as a reliable in-house midstream solution with over 99% uptime, making the onboarding process seamless and efficient for software developers and data analysts. It's designed to support the development of your scalable, mission-specific data processing pipelines from scratch. Tilebox empowers space companies to take full control and stay at the cutting edge of their midstream operations and paves the way for the integration of advanced technologies like AI and in-orbit computing.
BridgeLane Capital VC Fund · Sydney, New South Wales, Australia
The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme
Show more
Investment focus
  • Software, Financial Services, Health Care
  • Seed, Series B, Funding Round
  • Australia, Germany
Portfolio highlights
  • Evrima Technologies — Transforming clinical trial recruitment by connecting researchers, clinicians and patients together to accelerate research and bring new treatments to patients
  • Agerris — Agerris is a field robotics and AI start-up for the agriculture industry, based on technology created at the Australian Centre for Field Robotics, the University of Sydney, where they have been developing air and ground robotic solutions for the agriculture industry since 2005.
  • Sprout Stack
Global Health Investment Fund (GHIF) VC Fund · New York, New York, United States
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series B, Series C, Funding Round
  • United States, India, Austria
Portfolio highlights
  • CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
  • Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Allan Moss Angel · Sydney, New South Wales, Australia
Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Funding Round, Series A, Seed
  • Australia, United States, The Netherlands
Portfolio highlights
  • Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
Brisbane Angels VC Fund · Brisbane, Queensland, Australia
Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Angel, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • One Key Access — One Key Access is an interface to the world of couriers to enable 24/7 frictionless deliveries.
  • Tribu — Here at tribu we aim to make running an MSP stress-free and simple. Remove complexity and repetitive shackles to give you the freedom in business so that you can have freedom in life.
  • Kapiche — Instant insights. No set up or coding. The Kapiche feedback analytics platform helps you ingest and analyze mountains of customer feedback in minutes.
Vectr VC Fund · Sheung Wan, Hong Kong Island, Hong Kong · 7 investments in the past 12 months
Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.
Show more
Investment focus
  • FinTech, Artificial Intelligence, Financial Services
  • Seed, Series A, Pre-Seed
  • United States, Hong Kong, Singapore
Portfolio highlights
  • Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
  • MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
  • Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
Square Peg Capital VC Fund · Melbourne, Victoria, Australia · 26 investments in the past 12 months
Square Peg is a global investment firm on a mission to empower exceptional founders. With investing teams in Sydney, Melbourne, Tel Aviv, and Singapore, Square Peg invests in emerging technology companies across the internet economy.
Show more
Investment focus
  • Software, Internet, IT
  • Series A, Series B, Seed
  • Australia, United States, Singapore
Portfolio highlights
  • Partly — Auto parts distributors, manufacturers, dismantlers, marketplaces and software providers use Partly's software and API to add fitment and manage parts online.
  • ROKT — Rokt is the global leader in ecommerce technology & software solutions, driving more value per transaction with personalized experiences. Request a demo today.
  • SaasGuru — Get started with a personalised cert prep journey and make your certification goal a reality in two weeks. Salesforce and ServiceNow Certifications
Regal Funds Management VC Fund · Sydney, New South Wales, Australia · 5 investments in the past 12 months
Regal Funds Management aims to provide investors with absolute returns over the medium to long term, through a suite of investment products in both listed and unlisted equities. The Regal Emerging Companies Fund focuses on Pre-IPO, later stage VC, expansion capital and listed micro-cap opportunities.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Funding Round, Series B, Convertible Note
  • Australia, United States, United Kingdom
Portfolio highlights
  • Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
  • SendFX — SendFX provides cross-border payment and remittance services to individuals and SMEs.
  • Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
Innovation Capital VC Fund · Sydney, New South Wales, Australia
An Australian venture capital firm building global technology businesses
Show more
Investment focus
  • Software, Music and Audio, Internet
  • Funding Round, Series A
  • Australia
Portfolio highlights
  • Weathertrends 360 — Weathertrends 360 is a global, web solution.
  • VPIsystems — VPIsystems (formerly VPI Virtual Photonics) develops and markets network planning software and services for the telecommunications industry in the United States and internationally. Its products include Photonic Design Automation, a solution for the modeling and optimization of photonic components and subsystems; and OnePlan, an integrated networkplanning system that enables communications service providers, systems integrators, and manufacturers to design, plan, and implement their transition to an IP-based network. The company serves wireline, wireless, and broadband carriers; and network equipment manufacturers and optical equipment vendors. VPIsystems, Inc. has strategic alliances with Accenture, HP, Logica, and Tech Mahindra. The company was founded as VPI Virtual Photonics, Inc. in 1997 and changed its name to VPIsystems, Inc. in July 2001. VPIsystems, Inc. is based in Holmdel, New Jersey with additional offices in Europe, Asia, and Australia.
  • Audinate — Introducing Dante AV-H for H.26x video productsDante AV-H brings interoperability to AV-over-IP products, providing easy-to-use discovery, connectivity and manageability while using the familiar, reliable H.264/265 codecs already supported in common hardware./products/manufacturer-products/dante-av-video?link=hm-r2-lc-dc Dante Domain ManagerSecurity, organization, scalability, and control for Dante networksNow with control API so you can write code to integrate Dante with third-party products […]
Hitachi Ventures VC Fund · München, Bayern, Germany · 4 investments in the past 12 months
Hitachi Ventures invests in innovative companies that address society’s key technological challenges in areas like IT, industrial automation (robotics, sensor technology and IoT), cloud services (data management, cybersecurity), mobility (autonomous driving, mobility services, smart infrastructure and security services), energy, smart medicine (AIfor digital imaging, smart diagnostics, remote care), smart city, smart infrastructure and more. With our first fund of USD 150M, we invest in Series A/B/C rounds in globally leading startups. From our offices in Munich, Germany, and Boston, USA, we work tirelessly to develop close ties and effective collaboration with leading innovative technology hubs and like-minded co-investors. Hitachi intends to leverage its strong position in multiple global technology markets, its expertise and network to support and promote Hitachi Ventures portfolio companies.
Show more
Investment focus
  • Science/Engineering, Software, AI
  • Series C, Seed, Series A
  • United States, Australia, United Kingdom
Portfolio highlights
  • BeZero Carbon — BeZero Carbon is a global ratings agency for the Voluntary Carbon Market. Our carbon credit ratings allow all market participants to price and manage risk.
  • Proscia — Concentriq, our digital pathology platform, is redefining the pathology laboratory. Learn about our AI-powered, computational pathology software here.
  • Scipher Medicine — At Scipher Medicine, we are committed to transforming the way providers prescribe drugs, as well as the way manufacturers, develop new drugs. We have built a molecular map of all protein interactions that identifies genomic signatures and links those to disease and predictive treatment outcomes. Using a simple blood sample to analyze RNA, we canpredict if a patient is likely to respond to a targeted therapy before therapy is prescribed. This insight allows patients to start the most effective therapy from day one. For our first commercial product, we have developed PrismRA®, a first-of-its-kind blood test that can predict which patients with rheumatoid arthritis are less likely to respond to TNFi therapies such as Humira® and Enbrel® so that such patients can go on alternative approved drugs.We also used a different one for the ACO Payer Summit, I’ve provided that as well: Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today don't respond to treatment, costing the healthcare industry billions in wasted drugs while patients continue to suffer. Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A routine blood test predicts which drug he/she will respond to, with our first product focusing on rheumatoid arthritis, ensuring that the most optimal treatment is prescribed from day one. The molecular data generated by our tests is then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.
QIC BioVentures VC Fund · Brisbane, Queensland, Australia
QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Series A
  • Australia
Portfolio highlights
  • Protagonist Therapeutics — Protagonist Therapeutics is a biotechnology company dedicated to the discovery of novel peptide and small molecule compounds that mimic or inhibit therapeutically-relevant protein-protein interactions.
Twynam Agricultural Group VC Fund · Sydney, New South Wales, Australia · 3 investments in the past 12 months
Twynam Group is a leading Australian Funds Manager investing in early-stage climate tech. We also operate an agricultural and property portfolio.
Show more
Investment focus
  • Agriculture, Food Processing, Seafood
  • Series A, Seed, Funding Round
  • United States, Australia, Singapore
Portfolio highlights
  • Voltpost — The lamppost electric vehicle charger.
  • Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
  • Ocean Rainforest — Ocean Rainforest offer a collection of premium fully-traceable seaweed products, mostly for food and cosmetic producers.
AustralianSuper VC Fund · Melbourne, Victoria, Australia
AustralianSuper is run only to benefit members, offering low fees and strong long-term investment returns.
Show more
Investment focus
  • Information Technology, Hotel, Solar
  • Funding Round, Series A, Series C
  • Australia, United States, United Kingdom
Portfolio highlights
  • Peel Ports — Peel Ports is a unique network of strategically situated ports, terminals, hubs, shipping lines, and state-of-the-art services.
  • SiteMinder — SiteMinder is the world’s leading open hotel commerce platform, ranked among technology pioneers for opening up every hotel’s access to online commerce. It’s this central role that has earned SiteMinder the trust of tens of thousands of hotels, across 150 countries, to sell, market, manage and grow their business. The global company, headquarteredin Sydney with offices in Bangkok, Berlin, Dallas, Galway, London and Manila, generated more than 100 million reservations worth over US$35 billion in revenue for hotels in the last year prior to the start of the pandemic.
  • Generate Capital — Generate Capital is a finance company that builds, owns, and operates sustainable infrastructure to deliver affordable and reliable resource solutions. The company operates and finances assets in energy, mobility, and water resources.
BioScience Managers Limited VC Fund · Melbourne, Victoria, Australia
BioScience Managers Pty Ltd (formerly IB Managers) is a leading life sciences investment firm, headquartered in Melbourne, Australia. Established in 2003, BioScience Managers offers a global, multi-disciplinary team, bringing an international perspective together with the track record, networks and expertise required to convert that perspectiveinto informed, high return investment decisions.We operate a high value-add model, providing assistance and support to portfolio companies via our global team and international network of independent industry advisors. With combined experience of over 170 investments, more than 40 IPO’s/ reversals in Europe, the USA and Australia, and a diverse skillset specific to the bio-based industries, we aim to provide investee companies with significant value-add over and above capital invested.Alongside our funds management business, Phillip Bioscience Advisory provides specialist corporate advisory services to healthcare and life sciences companies.
Show more
Investment focus
  • Health Care, Pet, Medical
  • Funding Round
  • Canada, Australia
Portfolio highlights
  • Canary Medical — Canary is giving medical devices a voice and letting medical data be heard.
  • Nexvet — Our mission is to be a revolutionary force in the growing US$25 billion global animal pharmaceutical market. Only Nexvet can produce therapeutic antibodies that are 100% customised to target new species – like cats and dogs.Monoclonal antibody therapies have represented a new generation of highly effective, safe and targeted medicines inhumans. We think it’s time companion animals reaped the benefits of human medical progress in this field.Nexvet’s unique technology, PETisation™, ensures 100% customisation of a therapy to a new species, reducing the chances of immune challenges, and ensuring a more ‘natural’ fit between the therapy and the patient. Many chronic conditions in pets remain poorly treated by current veterinary therapies, such as pain and various inflammatory diseases– which has guided Nexvet’s focus towards these indications.To ensure we succeed in transforming animal medicine, we’ve brought together a team with an extraordinary global track record in animal and human health. We are working with leading contractors, advisors, drug development partners, academic groups, veterinarians and animal interest groups around the world to develop our pipeline to the highest standards.Senior executives and researchers from the world’s largest animal health brands are counted among our Board, management, and advisors, and together we’re building connections worldwide to make our vision a reality.
Lilly Ventures VC Fund · Indianapolis, Indiana, United States
Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of companies in its areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under managementand focuses on three major areas of interest. It partner actively with the management teams of its portfolio companies to realize the potential of their technologies.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Series C, Series B, Series A
  • United States, Israel, Australia
Portfolio highlights
  • IpiNovyx Bio — Orange Grove Bio partners with leading research universities to advance preclinical biotech programs in the oncology space. The company leverages its venture capital and drug development expertise to help patients and build biotech ecosystems.
  • Evox Therapeutics — Evox Therapeutics is harnessing and engineering the natural delivery capabilities of extracellular vesicles to develop an entirely novel class of biotherapeutics.
  • Kymera Therapeutics — Advancing targeted protein degradation to deliver next-generation medicines
Negev Capital VC Fund · Grand Cayman, Midland, Cayman Islands
Psychedelic Medical Intervention Investment Fund
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Seed, Series A, Series B
  • United States, Canada, Australia
Portfolio highlights
  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Mindstate Design Labs — A psychedelic drug development company designing altered states of consciousness for mental health therapeutics.
  • Delix Therapeutics — Rewiring the brain to heal the mind
Hostplus VC Fund · Melbourne, Victoria, Australia · 10 investments in the past 12 months
Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!
Show more
Investment focus
  • Science/Engineering, Software, Sustainability
  • Series B, Series C, Series A
  • Australia, United States, United Kingdom
Portfolio highlights
  • Oxbotica — Autonomous Vehicle Software - Any Vehicle, Any Place, Any Time
  • Diffblue — Diffblue helps accelerate your shift left by automatically writing suites of unit regression tests so you can catch errors faster and earlier in your pipeline
  • Vow — Vow is crafting a new category of food
Lionheart Ventures VC Fund · San Francisco, California, United States · 2 investments in the past 12 months
Lionheart Ventures is a global, seed-stage venture capital firm investing in companies that make humanity more resilient. Our focus areas are climate protection, mental health and financial inclusion.
Show more
Investment focus
  • Information Technology, Health Care, Environmental Engineering
  • Seed, Series A, Funding Round
  • United States, United Kingdom, Singapore
Portfolio highlights
  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Clerkenwell Health — Clerkenwell Health addresses the growing unmet demand for effective mental health treatments.
  • Trek Health — Trek Health builds foundational software that empowers mental health providers to start working with insurance networks. The company's contact modes are by mail, phone, and physical address.
Catherine Lacavera Angel
Catherine Lacavera is the VP, Legal at Google.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Seed, Pre-Seed
  • Canada, Australia
Portfolio highlights
  • Skritswap — skritswap software reduces the reading level of information.
  • HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
Daniel Petre Angel · Sydney, New South Wales, Australia
Daniel Petre is the Founder of StartGiving. He was a Founding Chairman and Board Member at Ninemsn. He attended the University of Sydney.
Show more
Investment focus
  • SaaS, Software, Banking
  • Seed, Pre-Seed, Series A
  • Australia
Portfolio highlights
  • Kismet — Find the best disability or healthcare service to support your journey
  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Ento — Manage compliance, increase revenue and reduce labour costs with Ento's single, HR, workforce management and onboarding software.
Investible VC Fund · Sydney, New South Wales, Australia · 22 investments in the past 12 months
Investible is an early-stage venture capital firm backing the visionaries advancing humanity through technology in Australia, New Zealand, Southeast Asia and globally.
Show more
Investment focus
  • Software, E-Commerce, Information Technology
  • Seed, Series A, Pre-Seed
  • Australia, United States, Singapore
Portfolio highlights
  • BintanGO — Creator Marketing Platform terbaik di Indonesia, lebih dari 40.000 Kreator dan 100 Brand sudah bergabung. Buat campaignmu jadi fleksibel, terlacak dan terukur.
  • Inspace XR — Inspire and engage prospective tenants, buyers, and your team with interactive virtual replicas of your assets, with 360 virtual tours, analytics & more.
  • Sherlok — Automated client retention for mortgage brokers, helping them grow their loan book by proactively keeping their existing clients happy and with them forever.
Tenacious Ventures VC Fund · Melbourne, Victoria, Australia · 3 investments in the past 12 months
Tenacious Ventures - Australia's first and only dedicated agrifood tech VC firm.
Show more
Investment focus
  • Agriculture, AgTech, Software
  • Seed, Series A, Pre-Seed
  • Australia, United States
Portfolio highlights
  • Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
  • SwarmFarm Robotics — Global crop protection specialists ADAMA and Australian ag-tech company.
  • Vow — Vow is crafting a new category of food
NOAB Ventures VC Fund · 2 investments in the past 12 months
NOAB Ventures operates as a venture capital firm.
Show more
Investment focus
  • Solar, Energy, Energy Storage
  • Pre-Seed, Funding Round
  • Australia, New Zealand
Portfolio highlights
  • HydGene Renewables — Our mission is to accelerate adoption of low carbon technology by providing an alternative green hydrogen solution.
  • Relectrify — Unlocking extra lifetime and performance of batteries via advanced battery management (BMS) technology.
  • Vertus Energy — We innovate to make fossil natural gas extinct.
Plymouth Growth VC Fund · Ann Arbor, Michigan, United States · 2 investments in the past 12 months
Growth Capital for Leading Midwest Tech Companies
Show more
Investment focus
  • Software, Information Technology, Enterprise Software
  • Series A, Funding Round, Series B
  • United States, Canada, Australia
Portfolio highlights
  • Forj — Host your association's conferences, trade shows, or events on our highly customizable and interactive virtual event platform, backed by our customer success team.
  • CloseSimple — CloseSimple is a real estate based software firm making conversation around buying or selling a house easier through Text Message & Email.
  • Deck Commerce — Deck Commerce Order Management System (OMS) simplifies complex order processes to empower retailers to curate the best customer experience.
Bioplatforms Australia VC Fund · Port Macquarie, New South Wales, Australia
Bioplatforms Australia is a non-profit entity that supports life science research in genomic, proteomics, metabolomics, and bioinformatics.
Show more
Investment focus
  • AgTech, Farming, Agriculture
  • Pre-Seed
  • Australia
Portfolio highlights
  • Number 8 bio — Number 8 bio objective is to decarbonize agriculture while feeding the world's rising population. This can be accomplished by harnessing the power of trillions of carbon-hungry bacteria that feed on harmful greenhouse gases and turn them into profitable animal feeds.
Australian Nuclear Science and Technology Organization VC Fund · Clayton, Victoria, Australia
Australian Nuclear Science and Technology Organisation is one of Australia's most important research infrastructures. Thousands of scientists in industry and academia gain access to state-of-the-art instruments every year. ANSTO operates much of Australia's landmark infrastructure, including OPAL, one of the world's most advancednuclear reactors; the Australian Synchrotron; the National Imaging Facility Research Cyclotron; and the Centre for Accelerator Science.
Show more
Investment focus
  • Health Care, Biotechnology, Pharmaceutical
  • Funding Round
  • Australia
Portfolio highlights
  • Clarity Pharmaceuticals — Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.
Time Ventures VC Fund · 3 investments in the past 12 months
Time Ventures is an investment fund for Marc Benioff.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Series A, Series B, Seed
  • United States, Canada, Germany
Portfolio highlights
  • ArteraAI — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
  • SandboxAQ — SandboxAQ is an enterprise SaaS company combining AI + Quantum tech to solve hard problems impacting society.
  • Dryad Networks — Overview of Dryad, providing ultra-early fire detection as well as forest growth and health monitoring.
Alium Capital VC Fund · Sydney, New South Wales, Australia
Alium Capital are Investment Fund Managers offering an Innovative Investment Fund Focused on Generating Returns & Effectively Managing Risk
Show more
Investment focus
  • Software, Financial, Science/Engineering
  • Series A, Series B, Seed
  • Australia, United States, Singapore
Portfolio highlights
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,091,001 freelance designers compete to create amazing designs for your business. Start Today!
  • Beforepay — Beforepay understands that traditional pay cycles are a form of financial stress. So we set out to find a better way, giving Australians the control and confidence that comes with managing your own money, on your terms.That’s why we created Pay On Demand™ - a service that allows you to access the money you have earned at work, when you choose todo so. After all, it is yours!The app also automatically predicts when your bills are due, shows you how much is OK for you to spend, and automatically creates budgets for you, effortlessly.
  • Alex — Alex is 100% digital, built from the ground up by an energetic team of bankers, focused on customer's needs, not ours. Further information regarding Alex’s restricted Banking Authority is available at www.alex.bank/legal
HealthCare Ventures VC Fund · Cambridge, Massachusetts, United States
HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Series A, Series C
  • United States, Australia, United Kingdom
Portfolio highlights
  • Colorescience — Know Better Skin with Colorescience. From mineral sunscreen to clinical skincare products, achieve a clear, even complexion and protect your skin from the damaging effects of the sun and environmental aggressors such as pollution. Shop Now!
  • Leap Therapeutics — Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
  • Proteostasis Therapeutics — Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, aredesigned to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
Mercia Fund Managers VC Fund · Henley In Arden, Warwickshire, United Kingdom · 7 investments in the past 12 months
Mercia Asset Management providing equity and debt to regional businesses with growth ambition. We are your capital partners from scale-up to exit.
Show more
Investment focus
  • Software, Health Care, Science/Engineering
  • Seed, Funding Round, Series A
  • United Kingdom, United States, Australia
Portfolio highlights
  • Role Mapper Technologies — Automate and transform how you design and manage job descriptions across your organisation. Hire, retain and grow an inclusive and diverse workforce with AI powered Intelligent Job Design.
  • Turbine — Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer.
  • Log my Care — Log My Care is a free electronic care planning and care management system for home care providers. Its platform provides a to-do log, which is shared with care employees to let them know their tasks and gives printable reports about activity performance that enable managers to operate care institutes in a hassle-free way.
Southern Cross Venture Partners VC Fund · North Sydney, New South Wales, Australia
Southern Cross Venture Partners was launched in 2006 by veteran venture capitalists who have managed and operated companies themselves. Southern Cross Venture Partners assist early stage technology companies that demonstrate the potential for exceptional growth and market leadership build significant businesses. The founding principle of SouthernCross is partnership -- they are passionately committed to doing everything they can to help their portfolio companies succeed. Their team has a strong record of utilizing their start-up and management experience, industry knowledge, network of business/customer relationships, and recruiting skills to assist in building significant shareholder value.Southern Cross is currently investing in companies that fit their investment criteria. They prefer to act as lead or co-lead in the early stages where they have experience that can help build value rapidly. They do not have a minimum investment amount, however, a typical initial investment will be $2 million to $5 million with an ability to invest more money in later rounds.
Show more
Investment focus
  • Software, Manufacturing, Renewable Energy
  • Funding Round, Series B, Series A
  • United States, Australia, Singapore
Portfolio highlights
  • Sunman — Sunman Energy is a technology company founded by a group of industry veterans delivering the future of Solar. Through the research and development of composite materials, Sunman has successfully commercialized the world’s first glass-free, lightweight and flexible Panel – eArc. Replacing glass completely, eArc brings solar power to markets andapplication scenarios that were previously impossible.
  • Wave Computing — The future of high-tech in online casino is a bright one. For example, RFID technology will help casinos track and identify stolen chips. In addition, these systems can also predict player behavior and betting patterns. The latter are especially useful if a player is caught while he is trying to switch out his cards. These ... Read more
  • Brisbane Materials Technology — Since 2005, we have helped thousands of people get the perfect domain name.
Giant Leap Fund VC Fund · Melbourne, Victoria, Australia · 5 investments in the past 12 months
Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.
Show more
Investment focus
  • Health Care, Software, Sustainability
  • Seed, Series A, Funding Round
  • Australia, United States, United Kingdom
Portfolio highlights
  • Mindset Health — Mindset Health is a digital therapeutics company that helps people manage chronic health issues like irritable bowel syndrome and anxiety with app-based hypnotherapy.
  • More Good Days — More Good Days offers evidence-based pain management programes, education, and health services.
  • Fortanix — Fortanix is building a new security category with its Runtime Encryption(R) technology using Intel SGX. Just like encryption today protects data at rest and data during motion, Runtime Encryption(R) keeps keys, data, and applications completely protected even when infrastructure has been compromised and even root users are malicious.Fortanix's Self-Defending Key Management Service (SDKMS) is a next-generation cloud native solution for your enterprise encryption needs. It offers key generation, management, distribution, encryption-as-a-service, HSM, KMIP, and tokenization all rolled-in as a single product the highest possible level of security and cloud scale. Available as both FIPS certified appliance and a globally available SaaS (with Equinix's strong SLA), SDKMS offers incredible simple central management, server-side load balancing, central tamper-proof logging, RESTful APIs, and Runtime Encryption(R) plugin to run custom code.Fortanix's Runtime Encryption(R) Platform allows customers to bring any docker container and run them securely inside Intel SGX without any modification. It allows customers to share data with each other without losing control of the data, run analytics on sensitive data, run applications securely in remote cloud, move PII-heavy sensitive data to public cloud, etc. Fortanix's Enclave Development Platform (EDP) allows customers to write Rust code to run natively as SGX enclaves. Supported by mainline Rust compiler, developers find EDP as the easiest and the most secure way of developing new applications.In the short time, Fortanix has developed strategic partnership with Equinix and IBM cloud and counts multiple F50 companies as its customers. Fortanix is a Gartner Cool Vendor and also was runner up in RSA Innovation Sandbox among 500+ security companies where judges called it "holy grail of security". Fortanix has more than ten patents pending for its innovation.
CP Ventures VC Fund · Sydney, New South Wales, Australia · 3 investments in the past 12 months
CP Ventures is a VC fund that invests internationally in early stage, highly scalable, breakthrough technology companies driven by the 4IR
Show more
Investment focus
  • Software, Artificial Intelligence, Machine Learning
  • Seed, Pre-Seed, Series A
  • Australia, United States, India
Portfolio highlights
  • Ahura AI — Ahura AI, an EdTech startup using artificial intelligence to create personalized learning tools that replicate a 1-to-1 learning experience
  • Anility — Embed financial health insights within your application using our world leading API service
  • Ensuredit — ENSUREDIT enables and empowers end customers and Insurance Intermediaries with AI-based product platforms for transformational customer experience.
Investors by industry
Investors by country
Investors in Australia by industry